Back to Results
First PageMeta Content
Pharmacology / Vaccines / Food and Drug Administration / Vaccination / Center for Biologics Evaluation and Research / Biologic / Whole blood / Influenza vaccine / Vaccinia / Medicine / Biotechnology / Biology


Science at CBER: Why, How, and What? SLIDE 1 This presentation will discuss science and, in particular, the research programs at the Center for Biologics; why CBER thinks they are so integral to the regulatory mission;
Add to Reading List

Open Document

File Size: 41,24 KB

Share Result on Facebook

Company

CBER / Sentinel / /

Facility

And building / /

IndustryTerm

manufacturing site inspection process / biological products / scientific technologies / biologics products / blood products / gene therapy products / analytical tools / biologic products / combination products / scientific technology / /

MedicalCondition

HIV / Guillain-Barre syndrome / vaccinia virus-infected mice / target cancer / injury / metastatic cancer / pandemic influenza / infectious diseases / vaccinia virus / seasonal flu / influenza / /

MedicalTreatment

gene therapy / /

Organization

FDA Science Board Subcommittee on Science and Technology / Division of Product Quality / office of Vaccines / Center for Biologics / office of Biostatistics and Epidemiology / FDA / Division of Viral Products / Promotions and Conversions Evaluation Committee / Division of Cell and Gene Therapy / Research Leadership Council / office of Blood / Medicare / /

Position

investigator / researcher / scientist / /

PublishedMedium

the Journal of Virology / /

RadioStation

26 What / /

Technology

Gene Therapy / DNA Chip / cell signaling / stem cells / apoptosis / /

SocialTag